Suppr超能文献

对接受结直肠癌筛查者的长期随访发现,使用16S rRNA和宏基因组测序在物种方面存在差异。

Long-term follow-up of colorectal cancer screening attendees identifies differences in spp. using 16S rRNA and metagenome sequencing.

作者信息

Bucher-Johannessen Cecilie, Birkeland Einar Elvbakken, Vinberg Elina, Bemanian Vahid, Hoff Geir, Berstad Paula, Rounge Trine B

机构信息

Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.

Department of Research, Cancer Registry of Norway, Oslo, Norway.

出版信息

Front Oncol. 2023 Apr 27;13:1183039. doi: 10.3389/fonc.2023.1183039. eCollection 2023.

Abstract

BACKGROUND

The microbiome has been implicated in the initiation and progression of colorectal cancer (CRC) in cross-sectional studies. However, there is a lack of studies using prospectively collected samples.

METHODS

From the Norwegian Colorectal Cancer Prevention (NORCCAP) trial, we analyzed 144 archived fecal samples from participants who were diagnosed with CRC or high-risk adenoma (HRA) at screening and from participants who remained cancer-free during 17 years of follow-up. We performed 16S rRNA sequencing of all the samples and metagenome sequencing on a subset of 47 samples. Differences in taxonomy and gene content between outcome groups were assessed for alpha and beta diversity and differential abundance.

RESULTS

Diversity and composition analyses showed no significant differences between CRC, HRA, and healthy controls. was more abundant in CRC compared with healthy controls in both the 16S and metagenome data. The abundance of and spp. was associated with time to CRC diagnosis.

CONCLUSION

Using a longitudinal study design, we identified three taxa as being potentially associated with CRC. These should be the focus of further studies of microbial changes occurring prior to CRC diagnosis.

摘要

背景

在横断面研究中,微生物群与结直肠癌(CRC)的发生和发展有关。然而,缺乏使用前瞻性收集样本的研究。

方法

从挪威结直肠癌预防(NORCCAP)试验中,我们分析了144份存档粪便样本,这些样本来自筛查时被诊断为CRC或高危腺瘤(HRA)的参与者,以及在17年随访期间未患癌症的参与者。我们对所有样本进行了16S rRNA测序,并对47个样本的子集进行了宏基因组测序。评估了结局组之间在分类学和基因含量上的差异,以分析α和β多样性以及差异丰度。

结果

多样性和组成分析显示,CRC、HRA和健康对照之间无显著差异。在16S和宏基因组数据中,与健康对照相比,CRC中的 更为丰富。 和 属的丰度与CRC诊断时间相关。

结论

采用纵向研究设计,我们确定了三个可能与CRC相关的分类群。这些应成为CRC诊断前发生的微生物变化进一步研究的重点。

相似文献

2
Species-level verification of association with colorectal cancer.
mSystems. 2024 Oct 22;9(10):e0073424. doi: 10.1128/msystems.00734-24. Epub 2024 Sep 17.
3
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
Front Cell Infect Microbiol. 2021 Feb 26;11:599734. doi: 10.3389/fcimb.2021.599734. eCollection 2021.
7
Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.
Front Cell Infect Microbiol. 2016 Dec 9;6:179. doi: 10.3389/fcimb.2016.00179. eCollection 2016.
8
A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer.
Invest New Drugs. 2022 Oct;40(5):884-894. doi: 10.1007/s10637-022-01263-1. Epub 2022 Jun 21.
9
16S rRNA Gene Sequencing for Deciphering the Colorectal Cancer Gut Microbiome: Current Protocols and Workflows.
Front Microbiol. 2018 Apr 27;9:767. doi: 10.3389/fmicb.2018.00767. eCollection 2018.
10
Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Res Microbiol. 2020 Apr-Jun;171(3-4):107-114. doi: 10.1016/j.resmic.2020.01.001. Epub 2020 Jan 24.

引用本文的文献

1
Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies.
Aliment Pharmacol Ther. 2025 Sep;62(6):568-584. doi: 10.1111/apt.70252. Epub 2025 Aug 12.
4
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.
J Gynecol Oncol. 2025 May;36(3):e38. doi: 10.3802/jgo.2025.36.e38. Epub 2024 Oct 21.
5
Species-level verification of association with colorectal cancer.
mSystems. 2024 Oct 22;9(10):e0073424. doi: 10.1128/msystems.00734-24. Epub 2024 Sep 17.
6
Genetic- and fiber-diet-mediated changes in virulence factors in pig colon contents and feces and their driving factors.
Front Vet Sci. 2024 Apr 16;11:1351962. doi: 10.3389/fvets.2024.1351962. eCollection 2024.
8
Breast cancer but not the menopausal status is associated with small changes of the gut microbiota.
Front Oncol. 2024 Jan 24;14:1279132. doi: 10.3389/fonc.2024.1279132. eCollection 2024.
9
Influence of perinatal and childhood exposure to tobacco and mercury in children's gut microbiota.
Front Microbiol. 2024 Jan 5;14:1258988. doi: 10.3389/fmicb.2023.1258988. eCollection 2023.

本文引用的文献

1
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.
2
The role of host heme in bacterial infection.
Biol Chem. 2022 Oct 14;403(11-12):1017-1029. doi: 10.1515/hsz-2022-0192. Print 2022 Nov 25.
3
Gut microbiome and its role in colorectal cancer.
BMC Cancer. 2021 Dec 11;21(1):1325. doi: 10.1186/s12885-021-09054-2.
4
Fecal Bacteria as Non-Invasive Biomarkers for Colorectal Adenocarcinoma.
Front Oncol. 2021 Aug 10;11:664321. doi: 10.3389/fonc.2021.664321. eCollection 2021.
6
Host variables confound gut microbiota studies of human disease.
Nature. 2020 Nov;587(7834):448-454. doi: 10.1038/s41586-020-2881-9. Epub 2020 Nov 4.
7
PICRUSt2 for prediction of metagenome functions.
Nat Biotechnol. 2020 Jun;38(6):685-688. doi: 10.1038/s41587-020-0548-6.
8
Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?
Trends Microbiol. 2020 May;28(5):401-423. doi: 10.1016/j.tim.2020.01.001. Epub 2020 Feb 13.
9
The Multifaceted Role of Heme in Cancer.
Front Oncol. 2020 Jan 15;9:1540. doi: 10.3389/fonc.2019.01540. eCollection 2019.
10
Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families.
Gut Microbes. 2020 Jul 3;11(4):918-929. doi: 10.1080/19490976.2020.1712986. Epub 2020 Jan 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验